149 related articles for article (PubMed ID: 27377965)
1. Nuclear translocation of IQGAP1 protein upon exposure to puromycin aminonucleoside in cultured human podocytes: ERK pathway involvement.
Rigothier C; Saleem MA; Bourget C; Mathieson PW; Combe C; Welsh GI
Cell Signal; 2016 Oct; 28(10):1470-8. PubMed ID: 27377965
[TBL] [Abstract][Full Text] [Related]
2. IQGAP1 regulates actin cytoskeleton organization in podocytes through interaction with nephrin.
Liu Y; Liang W; Yang Y; Pan Y; Yang Q; Chen X; Singhal PC; Ding G
Cell Signal; 2015 Apr; 27(4):867-77. PubMed ID: 25652011
[TBL] [Abstract][Full Text] [Related]
3. IQGAP1 interacts with components of the slit diaphragm complex in podocytes and is involved in podocyte migration and permeability in vitro.
Rigothier C; Auguste P; Welsh GI; Lepreux S; Deminière C; Mathieson PW; Saleem MA; Ripoche J; Combe C
PLoS One; 2012; 7(5):e37695. PubMed ID: 22662192
[TBL] [Abstract][Full Text] [Related]
4. The activation of extracellular signal-regulated kinase is responsible for podocyte injury.
Liu S; Ding J; Fan Q; Zhang H
Mol Biol Rep; 2010 Jun; 37(5):2477-84. PubMed ID: 19728154
[TBL] [Abstract][Full Text] [Related]
5. WT1-interacting protein and ZO-1 translocate into podocyte nuclei after puromycin aminonucleoside treatment.
Rico M; Mukherjee A; Konieczkowski M; Bruggeman LA; Miller RT; Khan S; Schelling JR; Sedor JR
Am J Physiol Renal Physiol; 2005 Aug; 289(2):F431-41. PubMed ID: 15798086
[TBL] [Abstract][Full Text] [Related]
6. The Ras GTPase-activating-like protein IQGAP1 is downregulated in human diabetic nephropathy and associated with ERK1/2 pathway activation.
Zhou H; Yao C; Bian A; Qian J; Zhao X; Zhao Y; Wang W; Xing C
Mol Cell Biochem; 2014 Jun; 391(1-2):21-5. PubMed ID: 24488174
[TBL] [Abstract][Full Text] [Related]
7. Puromycin aminonucleoside increases podocyte permeability by modulating ZO-1 in an oxidative stress-dependent manner.
Ha TS; Park HY; Seong SB; Ahn HY
Exp Cell Res; 2016 Jan; 340(1):139-49. PubMed ID: 26683996
[TBL] [Abstract][Full Text] [Related]
8. 1,25-Dihydroxyvitamin D(3) prevents puromycin aminonucleoside-induced apoptosis of glomerular podocytes by activating the phosphatidylinositol 3-kinase/Akt-signaling pathway.
Xiao H; Shi W; Liu S; Wang W; Zhang B; Zhang Y; Xu L; Liang X; Liang Y
Am J Nephrol; 2009; 30(1):34-43. PubMed ID: 19202327
[TBL] [Abstract][Full Text] [Related]
9. Smad3/Nox4-mediated mitochondrial dysfunction plays a crucial role in puromycin aminonucleoside-induced podocyte damage.
Yu L; Liu Y; Wu Y; Liu Q; Feng J; Gu X; Xiong Y; Fan Q; Ye J
Cell Signal; 2014 Dec; 26(12):2979-91. PubMed ID: 25229402
[TBL] [Abstract][Full Text] [Related]
10. IQGAP1 mediates podocyte injury in diabetic kidney disease by regulating nephrin endocytosis.
Liu Y; Su H; Ma C; Ji D; Zheng X; Wang P; Zheng S; Wang L; Wang Z; Xu D
Cell Signal; 2019 Jul; 59():13-23. PubMed ID: 30857827
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of nestin protects podocytes from apoptosis induced by puromycin aminonucleoside.
Wen D; You L; Zhang Q; Zhang L; Gu Y; Hao CM; Chen J
Am J Nephrol; 2011; 34(5):423-34. PubMed ID: 21952051
[TBL] [Abstract][Full Text] [Related]
12. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome.
Koshikawa M; Mukoyama M; Mori K; Suganami T; Sawai K; Yoshioka T; Nagae T; Yokoi H; Kawachi H; Shimizu F; Sugawara A; Nakao K
J Am Soc Nephrol; 2005 Sep; 16(9):2690-701. PubMed ID: 15987752
[TBL] [Abstract][Full Text] [Related]
13. Calcineurin inhibitors cyclosporin A and tacrolimus protect against podocyte injury induced by puromycin aminonucleoside in rodent models.
Shen X; Jiang H; Ying M; Xie Z; Li X; Wang H; Zhao J; Lin C; Wang Y; Feng S; Shen J; Weng C; Lin W; Wang H; Zhou Q; Bi Y; Li M; Wang L; Zhu T; Huang X; Lan HY; Zhou J; Chen J
Sci Rep; 2016 Sep; 6():32087. PubMed ID: 27580845
[TBL] [Abstract][Full Text] [Related]
14. Dynamics of absolute amount of nephrin in a single podocyte in puromycin aminonucleoside nephrosis rats calculated by quantitative glomerular proteomics approach with selected reaction monitoring mode.
Kawakami H; Kamiie J; Yasuno K; Kobayashi R; Aihara N; Shirota K
Nephrol Dial Transplant; 2012 Apr; 27(4):1324-30. PubMed ID: 21862459
[TBL] [Abstract][Full Text] [Related]
15. Trehalose, an mTOR independent autophagy inducer, alleviates human podocyte injury after puromycin aminonucleoside treatment.
Kang YL; Saleem MA; Chan KW; Yung BY; Law HK
PLoS One; 2014; 9(11):e113520. PubMed ID: 25412249
[TBL] [Abstract][Full Text] [Related]
16. A novel splicing variant of small nucleolar RNA host gene 4 is a podocyte-selective non-coding RNA upregulated in response to puromycin aminonucleoside-induced podocyte injury.
Horikawa A; Yoneda T; Yaoita E; Yamaguchi K; Shigenobu S; Kuramochi M; Yamate J; Inui T; Ishibashi O
J Biochem; 2019 May; 165(5):447-454. PubMed ID: 30597036
[TBL] [Abstract][Full Text] [Related]
17. The cytoprotective role of autophagy in puromycin aminonucleoside treated human podocytes.
Kang YL; Saleem MA; Chan KW; Yung BY; Law HK
Biochem Biophys Res Commun; 2014 Jan; 443(2):628-34. PubMed ID: 24333414
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the protein kinase MK-2 protects podocytes from nephrotic syndrome-related injury.
Pengal R; Guess AJ; Agrawal S; Manley J; Ransom RF; Mourey RJ; Benndorf R; Smoyer WE
Am J Physiol Renal Physiol; 2011 Sep; 301(3):F509-19. PubMed ID: 21613416
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of rituximab on puromycin-induced apoptosis, loss of adhesion and cytoskeletal alterations in human podocytes.
Jeruschke S; Alex D; Hoyer PF; Weber S
Sci Rep; 2022 Jul; 12(1):12297. PubMed ID: 35853959
[TBL] [Abstract][Full Text] [Related]
20. Slit diaphragm protein Neph1 and its signaling: a novel therapeutic target for protection of podocytes against glomerular injury.
Arif E; Rathore YS; Kumari B; Ashish F; Wong HN; Holzman LB; Nihalani D
J Biol Chem; 2014 Apr; 289(14):9502-18. PubMed ID: 24554715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
